Mean platelet volume in patients with idiopathic and ischemic cardiomyopathy (Author`s Reply)

References (3)

1. Açıkgöz N, Ermiş N, Yağmur J, Cansel M, Ataş H, Pekdemir H, et al. The evaluation of mean platelet volume levels in patients with idiopathic and ischemic cardiomyopathy: an observational study. Anadolu Kardiyol Derg 2011; 11: 595-9
2. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009; 63: 1509-15. [CrossRef] 3. Çoban E, Afacan B. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment. Platelets 2008; 19: 111-4. [CrossRef] 4. Bakovic D, Pivac N, Eterovic D, Palada I, Valic Z, Paukovic-Sekulic B, et al. Changes in platelet size and spleen volume in response to selective and non-selective beta-adrenoceptor blockade in hypertensive patients. Clin Exp Pharmacol Physiol 2009; 36: 441-6. [CrossRef] 5. Debili N, Masse JM, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the mega- karyocytic differentiation of CD34+ cells. Blood 1993; 82: 84-95
3. Yan AT, Yan RT, Cushman M, Redheuil A, Tracy RP Arnett DK, et al. Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi- Ethnic Study of Atherosclerosis. Eur Heart J 2010; 31: 875-82. [CrossRef] 7. Gasparyan AY, Ayvazyan L, Mikhailidis DP Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011; 17: 47-58. [CrossRef] 8. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8: 148-56. [CrossRef]